Skip to main navigation Skip to search Skip to main content

Oral administration of lactobacillus rhamnosus ameliorates the progression of osteoarthritis by inhibiting joint pain and inflammation

  • Catholic University of Korea
  • The Catholic University of Korea, College of Medicine

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Abstract

Osteoarthritis (OA) is the most common form of arthritis and age‐related degenerative joint disorder, which adversely affects quality of life and causes disability. However, the pathogenesis of OA remains unclear. This study was performed to examine the effects of Lactobacillus rhamnosus in OA progression. OA was induced in 6‐week‐old male Wistar rats by monosodium iodoacetate (MIA) injection, and the effects of oral administration of L. rhamnosus were examined in this OA rat model. Pain severity, cartilage destruction, and inflammation were measured in MIA‐induced OA rats. The small intestines were isolated from OA rats, and the intestinal structure and inflammation were measured. Protein expression in the dorsal root ganglion was analyzed by immunohistochemistry. The effects of L. rhamnosus on mRNA and protein expression in chondrocytes stimulated with interleukin (IL)‐1β and lipopolysaccharide (LPS) were analyzed by real‐time polymerase chain reaction (RT‐PCR) and enzyme‐linked immunosorbent assay (ELISA). Pain severity was decreased in L. rhamnosus‐treated MIA‐induced OA rats. The levels of expression of MCP‐1, a potential inflammatory cytokine, and its receptor, CCR2, were decreased, and GABA and PPAR‐γ expression were increased in L. rhamnosus‐treated OA rats. The inflammation, as determined by IL‐ 1β, and cartilage destruction, as determined by MMP3, were also significantly decreased by L. rhamnosus in OA rats. Additionally, intestinal damage and inflammation were improved by L. rhamnosus. In human OA chondrocytes, TIMP1, TIMP3, SOX9, and COL2A1 which are tissue inhibitors of MMP, and IL‐10, an anti‐inflammatory cytokine, were increased by L. rhamnosus. L. rhamnosus treatment led to decreased pain severity and cartilage destruction in a rat model of OA. Intestinal damage and inflammation were also decreased by L. rhamnosus treatment. Our findings suggested the therapeutic potential of L. rhamnosus in OA.

Original languageEnglish
Article number1057
JournalCells
Volume10
Issue number5
DOIs
StatePublished - May 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Lactobacillus rhamnosus
  • Microbiota
  • Monosodium iodoacetate (MIA), inflammation
  • Osteoarthritis

Fingerprint

Dive into the research topics of 'Oral administration of lactobacillus rhamnosus ameliorates the progression of osteoarthritis by inhibiting joint pain and inflammation'. Together they form a unique fingerprint.

Cite this